Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-24

FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) from Kenvue Brands LLC, likely for labeling or indication updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC ALLERGY (cetirizine hydrochloride)

Snippet

SUPPL AP for ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE)